Founders Bank & Trust’s Novartis NVS Stock Holding History

Founders Bank & Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$1.05M	Sell	12,629 -506	-4%	-$41.9K	0.55%	31
2014 Q3	$1.11M	Sell	13,135 -518	-4%	-$41.9K	0.62%	27
2014 Q2	$1.11M	Buy	13,653 +478	+4%	+$37.6K	0.61%	27
2014 Q1	$1M	Buy	13,175 +633	+5%	+$46.1K	0.58%	29
2013 Q4	$883K	Sell	12,542 -463	-4%	-$32.2K	0.51%	32
2013 Q3	$894K	Buy	13,005 +131	+1%	+$8.67K	0.46%	31
2013 Q2	$815K	Buy	+12,874	New	+$838K	0.44%	31

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Founders Bank & Trust's NVS Position: Q4 2014 in Review

Founders Bank & Trust reduced its Novartis (NVS) stake by 3.9% in Q4 2014, selling an estimated $41.9K and leaving 12,629 shares worth $1.05M. The position accounts for 0.55% of the portfolio, ranked #31.

Founders Bank & Trust first reported a position in NVS in Q2 2013 and has held it in 7 quarters since. The position peaked at $1.11M in Q3 2014. 919 funds tracked by Wall St. Rank hold NVS as of Q4 2014.

Founders Bank & Trust held 12,629 shares of Novartis worth $1.05M as of Q4 2014.
Founders Bank & Trust sold 506 Novartis shares in Q4 2014, an estimated $41.9K.
Novartis made up 0.55% of Founders Bank & Trust's portfolio in Q4 2014, its #31 holding.
Founders Bank & Trust first reported a position in Novartis in Q2 2013 and has held it in 7 quarters since.
Founders Bank & Trust's Novartis position peaked at $1.11M in Q3 2014.
919 funds tracked by Wall St. Rank held Novartis as of Q4 2014.

Based on Founders Bank & Trust's 13F filing for Q4 2014, filed 9 Feb 2015.